$155.42 +0.62 (0.40%) Amgen Inc - NASDAQ

Jan. 18, 2017 | 12:40 PM

Charts

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Key Statistics
Last Trade: 155.42
Trade Time: Jan 18 12:40 PM Eastern Daylight Time
Change: +0.62 (0.40%)
Prev Close: 154.80
Open: 155.69
Bid: 155.42
Ask: 155.46

Competitors

Ticker Name Volume % Change
ABBV Abbvie Inc. 7.76M -0.21%
EXEL Exelixis Inc. 4.27M -3.89%
MACK Merrimack Pharmaceuticals Inc. 3.93M -4.98%
ARNA Arena Pharmaceuticals, Inc. 3.09M -2.82%
BA The Boeing Company 2.76M -0.73%

AMGN Stock Analysis

Partner Headlines

  1. Lilly Regains Key Migraine Drug With $960 Million CoLucid Acquisition

    Investors Business Daily | Jan. 18, 2017 | 11:25AM EST
  2. Regeneron, Sanofi Claim Amgen's LDL-Buster Patent Too Broad

    Investors Business Daily | Jan. 17, 2017 | 15:52PM EST
  3. Odds Are Against Regeneron, Sanofi In Amgen Patent Battle: Leerink

    Investors Business Daily | Jan. 13, 2017 | 13:49PM EST
  4. Trump's 'Disastrous' Pharma View Doesn't Rattle JPMorgan Drug Conference

    Investors Business Daily | Jan. 13, 2017 | 07:30AM EST
  5. Trump Says Drugmakers 'Getting Away With Murder', Cites F-35, Ford, Fiat

    Investors Business Daily | Jan. 11, 2017 | 11:46AM EST
  6. Stocks Still Mixed, Medicals Lead Upside; Is Incyte The Next Amgen?

    Investors Business Daily | Jan. 9, 2017 | 13:43PM EST